目次

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Meningococcal Vaccines Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.2 Market Restraining Factors
3.2.3 Market Opportunities
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat of Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Meningococcal Vaccines Market Analysis by Type
4.1 Key Findings
4.2 Type Segment: Market Attractiveness Index
4.3 Meningococcal Vaccines Market Size Estimation and Forecast by Type
4.4 Polysaccharide vaccines
4.4.1 Polysaccharide Vaccines Market Forecast by Region, 2024-2034 (US$ Mn)
4.4.2 Polysaccharide vaccines Market Share by Region, 2024-2034 (%)
4.5 Conjugate vaccines
4.5.1 Conjugate Vaccines Market Forecast by Region, 2024-2034 (US$ Mn)
4.5.2 Conjugate vaccines Market Share by Region, 2024-2034 (%)
4.6 Combination vaccines
4.6.1 Combination Vaccines Market Forecast by Region, 2024-2034 (US$ Mn)
4.6.2 Combination Vaccines Market Share by Region, 2024-2034 (%)
4.7 Men B vaccines
4.7.1 Men B Vaccines Market Forecast by Region, 2024-2034 (US$ Mn)
4.7.2 Men B vaccines Market Share by Region, 2024-2034 (%)

5 Meningococcal Vaccines Market Analysis by Serogroups
5.1 Key Findings
5.2 Serogroups Segment: Market Attractiveness Index
5.3 Meningococcal Vaccines Market Size Estimation and Forecast by Serogroups
5.4 Meningococcal Vaccines Market Share by Serogroups, 2024 & 2034
5.5 A, B, C, Y, W-135 vaccines
5.5.1 A, B, C, Y, W-135 Vaccines Market Forecast by Region, 2024-2034 (US$ Mn)
5.5.2 A, B, C, Y, W-135 vaccines Market Share by Region, 2024-2034 (%)
5.6 Serogroup B vaccines
5.6.1 Serogroup Men B Vaccines Market Forecast by Region, 2024-2034 (US$ Mn)
5.6.2 Serogroup Men B Vaccines Market Share by Region, 2024-2034 (%)

6 Meningococcal Vaccines Market Analysis by Brand
6.1 Key Findings
6.2 Menactra
6.2.1 Menactra Market Forecast, 2024-2034 (US$ Mn)
6.3 Menveo
6.3.1 Menveo Market Forecast, 2024-2034 (US$ Mn)
6.4 Nimenrix
6.4.1 Nimenrix Market Forecast, 2024-2034 (US$ Mn)
6.5 Bexsero
6.5.1 Bexsero Market Forecast, 2024-2034 (US$ Mn)
6.6 Trumenba
6.6.1 Trumenba Market Forecast, 2024-2034 (US$ Mn)

7 Meningococcal Vaccines Market Analysis by Distribution Channel
7.1 Key Findings
7.2 Distribution Channel Segment: Market Attractiveness Index
7.3 Meningococcal Vaccines Market Size Estimation and Forecast by Distribution Channel
7.4 Meningococcal Vaccines Market Share by Distribution Channel, 2024, 2029, 2034
7.5 Hospital Pharmacies
7.5.1 Hospital Pharmacies Market Forecast by Region, 2024-2034 (US$ Mn)
7.5.2 Hospital Pharmacies Market Share by Region, 2024-2034 (%)
7.6 Retail Pharmacies
7.6.1 Retail Pharmacies Market Forecast by Region, 2024-2034 (US$ Mn)
7.6.2 Retail Pharmacies Market Share by Region, 2024-2034 (%)
7.7 Online Pharmacies
7.7.1 Online Pharmacies Market Forecast by Region, 2024-2034 (US$ Mn)
7.7.2 Online Pharmacies Market Share by Region, 2024-2034 (%)

8 Meningococcal Vaccines Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America Meningococcal Vaccines Market Analysis
9.1 Key Findings
9.2 North America Meningococcal Vaccines Market Attractiveness Index
9.3 North America Meningococcal Vaccines Market by Country, 2024, 2029 & 2034 (US$ Mn)
9.4 North America Meningococcal Vaccines Market Size Estimation and Forecast by Country
9.5 North America Meningococcal Vaccines Market Size Estimation and Forecast by Type
9.6 North America Meningococcal Vaccines Market Size Estimation and Forecast by Serogroups
9.7 North America Meningococcal Vaccines Market Size Estimation and Forecast by Distribution Channel
9.8 U.S.
9.8.1 U.S. Meningococcal Vaccines Market by Type
9.9 Canada
9.9.1 Canada Meningococcal Vaccines Market by Type

10 Europe Meningococcal Vaccines Market Analysis
10.1 Key Findings
10.2 Europe Meningococcal Vaccines Market Attractiveness Index
10.3 Europe Meningococcal Vaccines Market by Country, 2024, 2029 & 2034 (US$ Mn)
10.4 Europe Meningococcal Vaccines Market Size Estimation and Forecast by Country
10.5 Europe Meningococcal Vaccines Market Size Estimation and Forecast by Type
10.6 Europe Meningococcal Vaccines Market Size Estimation and Forecast by Serogroups
10.7 Europe Meningococcal Vaccines Market Size Estimation and Forecast by Distribution Channel
10.8 Germany
10.8.1 Germany Meningococcal Vaccines Market by Type
10.9 U.K.
10.9.1 U.K. Meningococcal Vaccines Market by Type
10.10 France
10.10.1 France Meningococcal Vaccines Market by Type
10.11 Italy
10.11.1 Italy Meningococcal Vaccines Market by Type
10.12 Spain
10.12.1 Spain Meningococcal Vaccines Market by Type
10.13 Rest of Europe
10.13.1 Rest of Europe Meningococcal Vaccines Market by Type

11 Asia Pacific Meningococcal Vaccines Market Analysis
11.1 Key Findings
11.2 Asia Pacific Meningococcal Vaccines Market Attractiveness Index
11.3 Asia Pacific Meningococcal Vaccines Market by Country, 2024, 2029 & 2034 (US$ Mn)
11.4 Asia Pacific Meningococcal Vaccines Market Size Estimation and Forecast by Country
11.5 Asia Pacific Meningococcal Vaccines Market Size Estimation and Forecast by Type
11.6 Asia Pacific Meningococcal Vaccines Market Size Estimation and Forecast by Serogroups
11.7 Asia Pacific Meningococcal Vaccines Market Size Estimation and Forecast by Distribution Channel
11.8 Japan
11.9 China
11.9.1 China Meningococcal Vaccines Market by Type
11.10 India
11.10.1 India Meningococcal Vaccines Market by Type
11.11 South Korea
11.11.1 South Korea Meningococcal Vaccines Market by Type
11.12 Australia
11.12.1 Australia Meningococcal Vaccines Market by Type
11.13 Rest of APAC
11.13.1 Rest of APAC Meningococcal Vaccines Market by Type

12 Latin America Meningococcal Vaccines Market Analysis
12.1 Key Findings
12.2 Latin America Meningococcal Vaccines Market Attractiveness Index
12.3 Latin America Meningococcal Vaccines Market by Country, 2024, 2029 & 2034 (US$ Mn)
12.4 Latin America Meningococcal Vaccines Market Size Estimation and Forecast by Country
12.5 Latin America Meningococcal Vaccines Market Size Estimation and Forecast by Type
12.6 Latin America Meningococcal Vaccines Market Size Estimation and Forecast by Serogroups
12.7 Latin America Meningococcal Vaccines Market Size Estimation and Forecast by Distribution Channel
12.8 Brazil
12.8.1 Brazil Meningococcal Vaccines Market by Type
12.9 Mexico
12.10 Rest of Latin America
12.10.1 Rest of LATAM Meningococcal Vaccines Market by Type

13 MEA Meningococcal Vaccines Market Analysis
13.1 Key Findings
13.2 MEA Meningococcal Vaccines Market Attractiveness Index
13.3 MEA Meningococcal Vaccines Market by Country, 2024, 2029 & 2034 (US$ Mn)
13.4 MEA Meningococcal Vaccines Market Size Estimation and Forecast by Country
13.5 MEA Meningococcal Vaccines Market Size Estimation and Forecast by Type
13.6 MEA Meningococcal Vaccines Market Size Estimation and Forecast by Serogroups
13.7 MEA Meningococcal Vaccines Market Size Estimation and Forecast by Distribution Channel
13.8 South Africa
13.8.1 South Africa Meningococcal Vaccines Market by Type
13.9 GCC
13.9.1 GCC Meningococcal Vaccines Market by Type
13.10 Rest of MEA
13.10.1 Rest of MEA Meningococcal Vaccines Market by Type

14 Competitive Landscape
14.1 Company Market Share Analysis
14.2 Key Business Strategy Analysis

15 Company Profiles
15.1 GSK plc
15.1.1 Company Snapshot
15.1.2 Company Overview
15.1.3 Financial Analysis
15.1.4 Product Benchmarking
15.1.5 Pipeline Analysis
15.1.6 Strategic Outlook
15.2 BIO-MED
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Product Benchmarking
15.3 Hualan Biological Bacterin Co., Ltd.
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Product Benchmarking
15.4 Incepta Pharmaceuticals Ltd.
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Product Benchmarking
15.5 JN International
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Product Benchmarking
15.6 Pfizer Inc.
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.4 Product Benchmarking
15.6.5 Strategic Outlook
15.7 Sanofi
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.4 Product Benchmarking
15.7.5 Pipeline Analysis
15.7.6 Strategic Outlook
15.8 Serum Institute of India Pvt. Ltd
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Product Benchmarking
15.8.4 Strategic Outlook
15.9 Walvax Biotechnology Co., Ltd.
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Product Benchmarking
15.9.4 Pipeline Analysis

16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players

List of Tables
Table 1 Meningococcal Vaccines Market Snapshot, 2024 & 2034 (US$ Million, CAGR %)
Table 2 Meningococcal Vaccine Market, By Region, 2024-2034 (US$ Mn, AGR %, CAGR %) (V-shaped Recovery)
Table 3 Meningococcal Vaccine Market, By Region, 2024-2034 (US$ Mn, AGR %, CAGR %) (U-shaped Recovery)
Table 4 Meningococcal Vaccine Market, By Region, 2024-2034 (US$ Mn, AGR %, CAGR %) (W-shaped Recovery)
Table 5 Meningococcal Vaccine Market, By Region, 2024-2034 (US$ Mn, AGR %, CAGR %) (L-shaped Recovery)
Table 6 Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 7 Polysaccharide Vaccines Market, by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 8 Conjugate Vaccines Market, by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 9 Combination Vaccines Market, by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 10 Men B Vaccines Market, by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 11 Meningococcal Vaccines Market by Serogroups, By Type 2024-2034 (US$ Million, AGR %, CAGR %)
Table 12 A, B, C, Y, W-135 Vaccines Market, by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 13 Men B Vaccines Market, by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 14 Menactra Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 15 Menveo Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 16 Nimenrix Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 17 Bexsero Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 18 Trumenba Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 19 Meningococcal Vaccines Meningococcal Vaccines Market by Distribution Channel, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 20 Hospital Pharmacies Market, by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 21 Retail Pharmacies Market, by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 22 Online Pharmacies Market, by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 23 Meningococcal Vaccines Market, By Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 24 North America Meningococcal Vaccines Market, By Country, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 25 North America Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 26 North America Meningococcal Vaccines Market by Serogroups, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 27 North America Meningococcal Vaccines Market by Distribution Channel, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 28 U.S. Meningococcal Vaccines Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 29 U.S. Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 30 Canada Meningococcal Vaccines Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 31 Canada Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 32 Europe Meningococcal Vaccines Market, By Country, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 33 Europe Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 34 Europe Meningococcal Vaccines Market by Serogroups, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 35 Europe Meningococcal Vaccines Market by Distribution Channel, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 36 Germany Meningococcal Vaccines Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 37 Germany Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 38 U.K. Meningococcal Vaccines Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 39 UK Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 40 France Meningococcal Vaccines Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 41 France Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 42 Italy Meningococcal Vaccines Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 43 Italy Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 44 Spain Meningococcal Vaccines Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 45 Spain Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 46 Rest of Europe Meningococcal Vaccines Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 47 Rest of Europe Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 48 Asia Pacific Meningococcal Vaccines Market, By Country, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 49 Asia Pacific Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 50 Asia Pacific Meningococcal Vaccines Market by Serogroups, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 51 Asia Pacific Meningococcal Vaccines Market by Distribution Channel, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 52 China Meningococcal Vaccines Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 53 China Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 54 India Meningococcal Vaccines Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 55 India Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 56 South Korea Meningococcal Vaccines Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 57 South Korea Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 58 Australia Meningococcal Vaccines Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 59 Australia Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 60 Rest of Asia Pacific Meningococcal Vaccines Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 61 Rest of Asia Pacific Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 62 Latin America Meningococcal Vaccines Market, By Country, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 63 Latin America Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 64 Latin America Meningococcal Vaccines Market by Serogroups, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 65 Latin America Meningococcal Vaccines Market by Distribution Channel, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 66 Brazil Meningococcal Vaccines Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 67 Brazil Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 68 Rest of LATAM Meningococcal Vaccines Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 69 Rest of LATAM Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 70 MEA Meningococcal Vaccines Market, By Country, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 71 MEA Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 72 MEA Meningococcal Vaccines Market by Serogroups, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 73 MEA Meningococcal Vaccines Market by Distribution Channel, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 74 South Africa Meningococcal Vaccines Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 75 South Africa Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 76 GCC Meningococcal Vaccines Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 77 GCC Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 78 Rest of MEA Meningococcal Vaccines Market, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 79 Rest of MEA Meningococcal Vaccines Market by Type, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 80 Key Business Strategies Adopted by Key Players in Meningococcal Vaccines Market Details
Table 81 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 GSK plc: Product Benchmarking
Table 83 GSK plc: Product Pipeline
Table 84 GSK plc: Company Recent Developments
Table 85 BIO-MED: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 BIO-MED: Product Benchmarking
Table 87 Hualan Biological Bacterin Co., Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Hualan Biological Bacterin Co., Ltd: Product Benchmarking
Table 89 Incepta Pharmaceuticals Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Incepta Pharmaceuticals Ltd.: Product Benchmarking
Table 91 JN International: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 JN International: Product Benchmarking
Table 93 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 Pfizer Inc.: Product Benchmarking
Table 95 Pfizer Inc.: Company Recent Developments
Table 96 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Sanofi: Product Benchmarking
Table 98 Sanofi: Product Pipeline
Table 99 Sanofi: Company Recent Developments
Table 100 Serum Institute of India Pvt. Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Serum Institute of India Pvt. Ltd: Product Benchmarking
Table 102 Serum Institute of India Pvt. Ltd: Company Recent Developments
Table 103 Walvax Biotechnology Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Walvax Biotechnology Co., Ltd.: Product Benchmarking
Table 105 Walvax Biotechnology Co., Ltd.: Product Pipeline
?

List of Figures
Figure 1 Meningococcal Vaccines Market Segmentation
Figure 2 Meningococcal Vaccines Market Forecast by Region: Market Attractiveness Index
Figure 3 Meningococcal Vaccines Market by Type: Market Attractiveness Index
Figure 4 Meningococcal Vaccines Market by Serogroups: Market Attractiveness Index
Figure 5 Meningococcal Vaccines Market by Distribution Channel: Market Attractiveness Index
Figure 6 Meningococcal Vaccines Market: Market Dynamics
Figure 7 Meningococcal Vaccines Market by Region, 2024-2034 (US$ Million, AGR %, CAGR %): “V” Shaped Recovery
Figure 8 Meningococcal Vaccines Market by Region, 2024-2034 (US$ Million, AGR %, CAGR %): “U” Shaped Recovery
Figure 9 Meningococcal Vaccines Market by Region, 2024-2034 (US$ Million, AGR %, CAGR %): “W” Shaped Recovery
Figure 10 Meningococcal Vaccines Market by Region, 2024-2034 (US$ Million, AGR %, CAGR %): “L” Shaped Recovery
Figure 11 Meningococcal Vaccines Market: Porter’s Five Forces Analysis
Figure 12 Meningococcal Vaccines Market: PEST Analysis
Figure 13 Meningococcal Vaccines Market Forecast by Type 2023 (Revenue, CAGR%)
Figure 14 Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 15 Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 16 Polysaccharide Vaccines Market Forecast by Region, 2024-2034 (US$ million)
Figure 17 Polysaccharide vaccines Market Share Forecast by Region, 2024-2034 (%)
Figure 18 Conjugate Vaccines Market Forecast by Region, 2024-2034 (US$ million)
Figure 19 Conjugate vaccines Market Share Forecast by Region, 2024-2034 (%)
Figure 20 Combination Vaccines Market Forecast by Region, 2024-2034 (US$ million)
Figure 21 Combination Vaccines Market Share Forecast by Region, 2024-2034 (%)
Figure 22 Men B Vaccines Market Forecast by Region, 2024-2034 (US$ million)
Figure 23 Men B vaccines Market Share Forecast by Region, 2024-2034 (%)
Figure 24 Meningococcal Vaccines Market Forecast by Serogroups 2023 (Revenue, CAGR%)
Figure 25 Meningococcal Vaccines Market Forecast by Serogroups, 2024-2034 (US$ Million, AGR %)
Figure 26 Meningococcal Vaccines Market Share Forecast by Serogroups, 2024, 2029, 2034 (%)
Figure 27 A, B, C, Y, W-135 Vaccines Market Forecast by Region, 2024-2034 (US$ million)
Figure 28 A, B, C, Y, W-135 vaccines Market Share Forecast by Region, 2024-2034 (%)
Figure 29 Serogroup Men B Vaccines Market Forecast by Region, 2024-2034 (US$ million)
Figure 30 Serogroup Men B Vaccines Market Share Forecast by Region, 2024-2034 (%)
Figure 31 Menactra Market Forecast, 2024-2034 (US$ million)
Figure 32 Menveo Market Forecast, 2024-2034 (US$ million)
Figure 33 Nimenrix Market Forecast, 2024-2034 (US$ million)
Figure 34 Bexsero Market Forecast, 2024-2034 (US$ million)
Figure 35 Trumenba Market Forecast, 2024-2034 (US$ million)
Figure 36 Meningococcal Vaccines Market Forecast by Distribution Channel 2023 (Revenue, CAGR%)
Figure 37 Meningococcal Vaccines Market Forecast by Distribution Channel, 2024-2034 (US$ Million, AGR %)
Figure 38 Meningococcal Vaccines Market Share Forecast by Distribution Channel, 2024, 2029, 2034 (%)
Figure 39 Hospital Pharmacies Market Forecast by Region, 2024-2034 (US$ million)
Figure 40 Hospital Pharmacies Market Share Forecast by Region, 2024-2034 (%)
Figure 41 Retail Pharmacies Market Forecast by Region, 2024-2034 (US$ million)
Figure 42 Retail Pharmacies Market Share Forecast by Region, 2024-2034 (%)
Figure 43 Online Pharmacies Market Forecast by Region, 2024-2034 (US$ million)
Figure 44 Online Pharmacies Market Share Forecast by Region, 2024-2034 (%)
Figure 45 Meningococcal Vaccines Market Forecast by Region 2024, 2034 (Revenue)
Figure 46 Meningococcal Vaccines Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 47 Meningococcal Vaccines Market by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Figure 48 North America Meningococcal Vaccines Market Attractiveness Index
Figure 49 North America Meningococcal Vaccines Market by Region, 2024, 2029 & 2034 (US$ million)
Figure 50 North America Meningococcal Vaccines Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 51 North America Meningococcal Vaccines Market Share Forecast by Country, 2024, 2029, 2034(%)
Figure 52 North America Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 53 North America Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 54 North America Meningococcal Vaccines Market Forecast by Serogroups, 2024-2034 (US$ Million, AGR %)
Figure 55 North America Meningococcal Vaccines Market Share Forecast by Serogroups, 2024, 2029, 2034 (%)
Figure 56 North America Meningococcal Vaccines Market Forecast by Distribution Channel, 2024-2034 (US$ Million, AGR %)
Figure 57 North America Meningococcal Vaccines Market Share Forecast by Distribution Channel, 2024, 2029, 2034 (%)
Figure 58 U.S. Meningococcal Vaccines Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 59 U.S. Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 60 U.S. Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 61 Canada Meningococcal Vaccines Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 62 Canada Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 63 Canada Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 64 Europe Meningococcal Vaccines Market Attractiveness Index
Figure 65 Europe Meningococcal Vaccines Market by Region, 2024, 2029 & 2034 (US$ million)
Figure 66 Europe Meningococcal Vaccines Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 67 Europe Meningococcal Vaccines Market Share Forecast by Country, 2024, 2029, 2034 (%)
Figure 68 Europe Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 69 Europe Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 70 Europe Meningococcal Vaccines Market Forecast by Serogroups, 2024-2034 (US$ Million, AGR %)
Figure 71 Europe Meningococcal Vaccines Market Share Forecast by Serogroups, 2024, 2029, 2034 (%)
Figure 72 Europe Meningococcal Vaccines Market Forecast by Distribution Channel, 2024-2034 (US$ Million, AGR %)
Figure 73 Europe Meningococcal Vaccines Market Share Forecast by Distribution Channel, 2024, 2029, 2034 (%)
Figure 74 Germany Meningococcal Vaccines Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 75 Germany Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 76 Germany Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 77 UK Meningococcal Vaccines Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 78 U.K. Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 79 U.K. Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 80 France Meningococcal Vaccines Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 81 France Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 82 France Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 83 Italy Meningococcal Vaccines Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 84 Italy Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 85 Italy Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 86 Spain Meningococcal Vaccines Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 87 Spain Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 88 Spain Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 89 Rest of Europe Meningococcal Vaccines Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 90 Rest of Europe Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 91 Rest of Europe Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 92 Asia Pacific Meningococcal Vaccines Market Attractiveness Index
Figure 93 Asia Pacific Meningococcal Vaccines Market by Region, 2024, 2029 & 2034 (US$ million)
Figure 94 Asia Pacific Meningococcal Vaccines Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 95 Asia Pacific Meningococcal Vaccines Market Share Forecast by Country, 2024, 2029, 2034 (%)
Figure 96 Asia Pacific Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 97 Asia Pacific Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 98 Asia Pacific Meningococcal Vaccines Market Forecast by Serogroups, 2024-2034 (US$ Million, AGR %)
Figure 99 Asia Pacific Meningococcal Vaccines Market Share Forecast by Serogroups, 2024, 2029, 2034 (%)
Figure 100 Asia Pacific Meningococcal Vaccines Market Forecast by Distribution Channel, 2024-2034 (US$ Million, AGR %)
Figure 101 Asia Pacific Meningococcal Vaccines Market Share Forecast by Distribution Channel, 2024, 2029, 2034 (%)
Figure 102 China Meningococcal Vaccines Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 103 China Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 104 China Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 105 India Meningococcal Vaccines Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 106 India Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 107 India Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 108 South Korea Meningococcal Vaccines Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 109 South Korea Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 110 South Korea Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 111 Australia Meningococcal Vaccines Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 112 Australia Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 113 Australia Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 114 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 115 Rest of APAC Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 116 Rest of APAC Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 117 Latin America Meningococcal Vaccines Market Attractiveness Index
Figure 118 Latin America Meningococcal Vaccines Market by Region, 2024, 2029 & 2034 (US$ million)
Figure 119 Latin America Meningococcal Vaccines Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 120 Latin America Meningococcal Vaccines Market Share Forecast by Country, 2024, 2029, 2034 (%)
Figure 121 Latin America Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 122 Latin America Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 123 Latin America Meningococcal Vaccines Market Forecast by Serogroups, 2024-2034 (US$ Million, AGR %)
Figure 124 Latin America Meningococcal Vaccines Market Share Forecast by Serogroups, 2024, 2029, 2034 (%)
Figure 125 Latin America Meningococcal Vaccines Market Forecast by Distribution Channel, 2024-2034 (US$ Million, AGR %)
Figure 126 Latin America Meningococcal Vaccines Market Share Forecast by Distribution Channel, 2024, 2029, 2034 (%)
Figure 127 Brazil Meningococcal Vaccines Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 128 Brazil Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 129 Brazil Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 130 Rest of LATAM Meningococcal Vaccines Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 131 Rest of LATAM Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 132 Rest of LATAM Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 133 MEA Meningococcal Vaccines Market Attractiveness Index
Figure 134 MEA Meningococcal Vaccines Market by Region, 2024, 2029 & 2034 (US$ million)
Figure 135 MEA Meningococcal Vaccines Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 136 MEA Meningococcal Vaccines Market Share Forecast by Country, 2024, 2029, 2034 (%)
Figure 137 MEA Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 138 MEA Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 139 MEA Meningococcal Vaccines Market Forecast by Serogroups, 2024-2034 (US$ Million, AGR %)
Figure 140 MEA Meningococcal Vaccines Market Share Forecast by Serogroups, 2024, 2029, 2034 (%)
Figure 141 MEA Meningococcal Vaccines Market Forecast by Distribution Channel, 2024-2034 (US$ Million, AGR %)
Figure 142 MEA Meningococcal Vaccines Market Share Forecast by Distribution Channel, 2024, 2029, 2034 (%)
Figure 143 South Africa Meningococcal Vaccines Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 144 South Africa Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 145 South Africa Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 146 GCC Meningococcal Vaccines Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 147 GCC Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 148 GCC Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 149 Rest of MEA Meningococcal Vaccines Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 150 Rest of MEA Meningococcal Vaccines Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 151 Rest of MEA Meningococcal Vaccines Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 152 Meningococcal Vaccines Market: Company Market Share Analysis, 2022
Figure 153 GSK plc: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 154 GSK plc: Regional Market Shares, 2022
Figure 155 GSK plc: R&D, 2018-2022 (US$ Million, AGR %)
Figure 156 Pfizer Inc.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 157 Pfizer Inc.: Regional Market Shares, 2022
Figure 158 Pfizer Inc.: R&D, 2018-2022 (US$ Million, AGR %)
Figure 159 Sanofi: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 160 Sanofi: Regional Market Shares, 2022
Figure 161 Sanofi: R&D, 2018-2022 (US$ Million, AGR %)